Compare Cloudflare Inc (NET) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cloudflare Inc vs Sana Biotechnology Inc — how do they compare? Cloudflare Inc trades at $271.31 (market cap $96.69B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Cloudflare Inc is far larger — about 110.6× Sana Biotechnology Inc's market cap, and Cloudflare Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| NET | SANA | |
|---|---|---|
Market Cap | $96.69B | $873.84M |
Sector | Technology | Health |
52-Week High | $281.69 | $5.92 |
52-Week Low | $160.16 | $2.68 |
Enterprise Value | $96.05B | $848.03M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $272.20, down 1.95% over 24 hours, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats but remains unprofitable, with a negative net income margin of -3.72% despite robust revenue growth to $2.17 billion in 2025. Operating cash flow improved to $603 million, though high valuation multiples like P/S of 40.96 and EV/EBITDA of 696.61 reflect premium pricing. Recent news highlights institutional interest and cybersecurity sector tailwinds.
Outlook is cautiously optimistic given analyst consensus of 72.5% buy ratings and a $271 price target near current levels. Key opportunities include AI-driven cybersecurity demand and revenue momentum, but risks encompass persistent losses, elevated debt, and competitive pressures. Investors should weigh growth potential against profitability challenges and market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
